Biodegradable microparticles of influenza viral vaccine: Comparison of the effects of routes of administration on the in vivo immune response in mice

Journal of Controlled Release

Volumn 58, Issue 2, 1999, Pages 223-232

  Chattaraj, Sarat C ^a   Rathinavelu, Appu ^a   Das, Sudip K ^a  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

IgG and IgA response; Influenza viral vaccine; Microparticle; Oral and subcutaneous administration; Poly(D,L lactide co glycolide); Poly(isobutylcyanoacrylate)

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFLUENZA VACCINE; POLY(ISOBUTYL 2 CYANOACRYLATE); POLYGLACTIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENCAPSULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOGENICITY; INFLUENZA; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BIOTRANSFORMATION; CHEMISTRY, PHYSICAL; CYANOACRYLATES; DRUG COMPOUNDING; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EXCIPIENTS; IMMUNOBLOTTING; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFLUENZA VACCINES; LACTIC ACID; MALE; MICE; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PARTICLE SIZE; POLYGLYCOLIC ACID; POLYMERS;

EID: 0032995755     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(98)00161-8     Document Type: Article

References (49)

1. E.D. Kilbourne, Inactivated influenza vaccines, in: S.A. Plotkin, E.A. Mortimer, Jr. (Eds.), Vaccines, W.B. Saunders, Philadelphia, 1988, pp. 420-434.
2. Waldman R.H., Stone J., Bergman K.C. Secretory antibody following oral influenza immunization. Am. J. Med. Sci. 292:1986;367-371.
3. Renegar K.B., Small P.A. Jr. Immunoglobulin A mediation of murine nasal anti-influenza virus immunity. J. Virol. 65:1996;2146-2148.
4. Renegar K.B., Small P.A. Jr. Passive transfer of local immunity to influence virus infection by IgA antibody. J. Immunol. 146:1986;1972-1978.
5. Bergmann K.C., Waldman R.H. Antibodies against influenza and stimulated macrophages in the lung lavage fluid of mice following oral immunization. Allerg. Immunol. 29:1983;215-222.
6. Waldman R.H., Bergmann K.C., Stone J., Howard S., Chiodo V., Jacknowitz A., Waldman E.R., Khakoo R. Age-dependent antibody response in mice and humans following oral influenza immunization. J. Clin. Immunol. 7:1987;327-332.
7. Meitin C.A., Bender B.S., Small P.A. Jr. Enteric immunization of mice against influenza with recombinant vaccinia. Proc. Natl. Acad. Sci. USA. 91:1984;11187-11191.
8. Chen K.S., Quinnan G.V. Jr. Induction, persistence and strain specificity of haemoagglutinin - specific secretory antibodies in lungs of mice after intragastric administration of inactivated influenza virus vaccines. J. Gen. Virol. 69:1988;2779-2784.
9. Moldoveanu Z., Novak M., Huang W.Q., Gilley R.M., Staas J.K., Shafer D.P., Compans R.W., Mestecky J. Oral immunization with influenza virus in microspheres. J. Infect. Dis. 167:1993;84-90.
10. Eldridge J.H., Hammond C.J., Meulbroek J.A., Staas J.K., Gilley R.M., Tice T.R. Controlled vaccine release in gut associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's Patches. J. Control. Release. 11:1990;205-214.
11. Pang G.T., Clancy R.L., O'Reilly S.E., Cripps A.W. A novel particulate influenza vaccine induces long-term and broad-based immunity in mice after oral immunization. J. Virol. 66:1992;1162-1170.
12. Lovgren K. The serum antibody response distributed in subclasses and isotypes after intranasal and subcutaneous immunization with influenza virus immunostimulating complexes. Scand. J. Immunol. 27:1988;241-245.
13. Hirabayashi T., Kurata H., Funato H., Nagamine T., Aizawa C., Tamura S., Shimada K., Kurata T. Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination. Vaccine. 8:1990;243-248.
14. Bergman K.C., Waldman R.H. Enhanced murin respiratory tract IgA antibody response to oral influenza vaccine when combined with a lipoidal amine (acridine). Int. Arch. Allergy Appl. Immunol. 87:1988;334-335.
15. Moldoveanu Z., Clements M.L., Prince S.J., Murphy B.R., Mestecky J. Human immune responses to influenza virus vaccines administered by systemic or mucosal routes. Vaccine. 13:1997;1006-1012.
16. McGhee J.R., Mestecky J., Dertzbaugh M.T., Eldridge J.H., Hirasawa M., Kiyono H. The mucosal immune system: From fundamental concepts to vaccine development. Vaccine. 10:1992;75-88.
17. Owen R.L., Ermak T.H. Structural specializations for antigen uptake and processing in the digestive tract. Springer Semin. Immunopathol. 12:1990;139-152.
18. Stoolman L.M. Adhesion molecules controlling lymphocyte migration. Cell. 56:1989;907-910.
19. Mestecky J., McGhee J.R. Immunoglobulin A (IgA): Molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv. Immunol. 40:1987;153-245.
20. Aguado M.T. Future approaches to vaccine development: Single dose vaccines using controlled release delivery systems. Vaccine. 11:1993;596-597.
21. Eldridge J.H., Stass J.K., Meulbroek J.A., McGhee J.R., Tice T.R., Gilley R.M. Biodegradable microspheres as a vaccine delivery system. Mol. Immunol. 28:1991;287-294.
22. Alonso M.J., Gupta R.K., Caroline M., Siber G.R., Langer R. Biodegradable microspheres as controlled release tetanus toxoid delivery systems. Vaccine. 12:1994;299-306.
23. Eldridge J.H., Meulbroek J.A., Staas J.K., Tice T.R., Gilley R.M. Vaccine containing biodegradable microspheres specifically enter the gut-associated lymphoid tissue following oral administration and induce a disseminated mucosal immune response. Adv. Exp. Med. Biol. 251:1989;192-202.
24. O'Hagan D.T. Intestinal translocation of particulates. Implications for drug and antigen delivery. Adv. Drug Del. Rev. 5:1990;265-285.
25. Hodges G.M., Carr E.A., Hassard R.A. dK.E, Carr K.E. Uptake and translocation of microparticles in small-intestine. Morphology and quantification of particle distribution. Dig. Dis. Sci. 40:1995;967-975.
26. Ermak T.H., Dougherty E.P., Bhagat H.R., Kabok Z., Pappo J. Uptake and transport of copolymer biodegradable microspheres by rabbit Peyer-Patch M cells. Cell Tissue Res. 279:1995;433-436.
27. Eldridge J.H., Gilley R.M., Staas J.K., Moldoveanu Z., Meulbroek J., Tice T.R. Biodegradable microspheres: vaccine delivery system for oral immunization. Curr. Top. Microbiol. Immunol. 146:1989;59-66.
28. S.C. Chattaraj, S.K. Das, Interference of thimerosal in bichinchoninic acid protein assay method, in preparation.
29. J.M. Walker, The bicinchoninic acid (BCA) assay for protein quantitation, in: Methods in Molecular Biology, Vol. 32: Basic Peptide and Protein Protocols, Humana, NJ, 1994, pp.5-8.
30. Jefferey H., Davis S.S., O'Hagan D.T. The preparation and characterization of poly(lactide-co-glycolide) Microparticles II. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique. Pharm. Res. 10:1993;362-368.
31. Das S.K., Coons P. Effect of formulation parameters on physicochemical characteristics of biodegradable polyester microspheres. Pharm. Res. 12:1995;S259.
32. Chattaraj S.C., Das S.K. Oral delivery of viral influenza vaccine using polyester and polyalkylcyanoacrylate microparticles. Pharm. Res. 13:1996;S163.
33. Das S.K., Tucker I.G., Hill D.J.T., Ganguly N. Evaluation of poly(isobutylcyanoacrylate) nanoparticles for mucoadhesive ocular drug delivery. I. Effect of formulation variables on physicochemical characteristics of nanoparticles. Pharm. Res. 12:1995;534-540.
34. Hora M.S., Rana R.K., Nunberg J.H., Tice T.R., Gilley R.M., Hudson M.E. Release of human serum albumin from the poly(lactide-co-glycolide) microspheres. Pharm. Res. 7:1990;1190-1194.
35. Smith P.K., Krohn R.I., Hermanson A.K., Mallia A.K., Garterner F.H., Provenzano M.D., Fujimoto E.K., Geoke N.M., Olsen B.J., Klenk D.C. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:1985;76-85.
36. Elson C.O., Ealding W., Lefkowitz J. A lavage technique allowing repeated measurement of IgA in mouse intestinal secretions. J. Immunol. Meth. 67:1984;101-108.
37. Muller R.H., Lherm C., Herbort J., Blunk T., Couvreur P. Alkylcyanoacrylate drug carriers: I. Physicochemical characterization of nanoparticles with different alkyl chain length. Int. J. Pharm. 84:1992;1-11.
38. Illum L., Khan M.A., Mak E., Davis S.S. Evaluation of carrier capacity and release characteristics of poly(butyl-2-cyanoacrylate) nanoparticles. Int. J. Pharm. 30:1986;17-28.
39. Leonard F., Kulkarni R.K., Brandes G., Nelson J., Cameron J.J. Synthesis and degradation of poly(alkyl-α-cyanoacrylates). J. Appl. Polymer Sci. 10:1966;259-272.
40. Park T.G., Lu W., Crotts G. Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly(D,L-lactic acid-co-glycolic acid) microspheres. J. Control. Release. 33:1995;211-222.
41. Pitt C.G., Gratzel M.M., Kimmel M.M., Surles J., Schlinder A. Aliphatic polyesters: II. The degradation of poly(D,L-lactide), poly(caprolactone) and their copolymers in vivo. Biomaterials. 2:1981;215-220.
42. O'Hagan D.T., Jeffery H., Davis S.S. The preparation and characterization of poly(lactide-co-glycolide) microparticles: III. Microparticle/polymer degradation rates and the in vitro release of a model protein. Int. J. Pharm. 103:1994;37-45.
43. Miller R.A., Brady J.M., Cutright D.W. Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification with changes in PLG/PGA copolymer ratios. J. Biomed. Mater. Res. 11:1977;711-719.
44. Ebel J.P. A method for quantifying particle absorption from small intestine of mouse. Pharmacol. Res. 7:1990;848-851.
45. Treanor J.J., Mattison H.R., Dumyati G., Yinon A., Erb S., O'Brien D., Dolin R., Betts R., Betts R.F. Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly. Ann. Intern. Med. 117:1992;625-633.
46. Lenaerts V., Couvreur P., Christiaens-Leyh D., Joiris E., Roland M., Rollman B., Speiser P. Degradation of poly(isobutylcyanoacrylate)nanoparticles. Biomaterials. 5:1984;65-68.
47. Farag-Mahmoud F.I., Wyde P.R., Rosborough J.P., Six H.R. Immunogenicity and efficacy of orally administered inactivated influenza virus vaccine in mice. Vaccine. 6:1988;262-268.
48. O'Hagan D.T. Oral delivery of vaccines: Formulation and clinical pharmacokinetic considerations. Clin. Pharmacokin. 22:1992;1-10.
49. Gilligan C.A., Li Wan Po A. Oral vaccines: Design and delivery. Int. J. Pharm. 73:1991;1-24.